Sentence examples for combo therapy from inspiring English sources

That indicates that the anti-HIV drugs used in combo therapy improved during the decade, having more power and fewer side effects, says Hogg.

Additionally, the phenotype and BV/TV ratios were similar in axitinib alone or combo therapy groups.

To more precisely evaluate specific cell types, tumours were digested and subjected to FACS. Figure 2A shows that DMXAA, Ad.E7, and combo therapy all mildly but significantly (P<0.05) increased macrophages (defined as CD11b+/CD11c−/Ly6G−) and DCs (defined as CD11b+/CD11c+/Ly6G−) to a similar same extent compared with control tumours, with cell percentages increasing by ∼30 70%.

These questions are particularly salient as formularies in many countries require the use of MTX mono and MTX combo therapies before reimbursing for the more expensive biological drugs.

The ACR responses were available in two of eight trials (158 patients) that compared MTX mono with MTX combo therapies in non-MTX inadequate responders (fig 4).

The ACR responses were available in four of five trials (552 patients) that compared MTX mono with MTX combo therapies in MTX inadequate response patients (fig 3).

Multiple TRAIL-based (combo) therapies are currently explored in vitro and in clinical trials, including the cancer therapeutic potential of recombinant TRAIL, humanized TRAIL receptor-activating antibodies, TRAIL mimetic peptides, and combinatorial treatments using recombinant TRAIL and irradiation or chemotherapeutics.

5 29 32 The ACR responses were available in three of the six trials that compared MTX mono with MTX combo therapies in MTX naïve patients (fig 2).These trials included a total of 287 patients.

Here, we show that the individual immunoreactivity in patients with IBD or AIH depending on long-term IS mono- or combo-therapy is not markedly disturbed.

The aim of the present study was to evaluate vascular healing of the bioengineered COMBO Dual Therapy Stent compared with a cobalt-chromium (CoCr) everolimus-eluting stent (EES) as assessed by optical coherence tomography in patients with acute coronary syndromes.

In particular, the COMBO dual therapy stent, being associated with early re-endothelialization, may allow for a reduction of the duration of DAPT without increasing the thrombotic risk, while reducing the risk of bleeding complications.